Gary Hamilton, PA

Gary Hamilton practices at Ophthalmic Consultants of Texas P.A. in Harlingen, Texas.

Gary Hamilton's NPI, 1528660925, was assigned on November 10, 2020. Gary Hamilton holds Texas license PA14076.

Gary Hamilton's primary practice is Ophthalmic Consultants of Texas P.A., at 1205 N Ed Carey Dr, Harlingen, TX 78550 in Cameron County. The practice phone is (956) 423-2100.

Gary Hamilton's primary practice is Ophthalmic Consultants of Texas P.A. in Harlingen, Texas. The medical group on file is Beyond Inpatient Services PLLC. Dmand AI also links Gary Hamilton to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gary Hamilton practices. Vendor and product names are available with a free account.

Physician assistant is Gary Hamilton's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Gary Hamilton is licensed in Texas.

CMS data shows 388 Medicare services from Gary Hamilton across 5 procedure codes in 2024, for 123 Medicare patients. Medicare paid $32,451 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 123 Medicare patients who saw Gary Hamilton in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gary Hamilton's median patient age at 48, with 70% women.

In 2024, Gary Hamilton wrote 345 Medicare Part D claims for 186 patients. 92% of them were for generic drugs. CMS names the drug for 130 of them, across 6 drugs with 11 or more claims each, at $710 in total drug cost.

Gary Hamilton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Gary Hamilton from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $69.